Kamomis is a refined botulinum toxin product from South Korea’s Maypharm Co. The products reduce moderate to severe facial wrinkles and address specific muscle concerns. Kamomis uses an advanced vacuum dehydration process for product stability. Each vial includes 100 units of active Clostridium Botulinum Toxin Type A, combined with human serum albumin and sodium chloride for optimal formulation. To prepare, the lyophilized powder is dissolved in a sterile 0.9% sodium chloride solution.